Author:
Glezerman Ilya G.,Pietanza M. Catherine,Miller Vincent,Seshan Surya V.
Reference16 articles.
1. Pharmacology and mechanism of action of pemetrexed;Adjei;Clin Lung Cancer,2004
2. Pemetrexed, a novel antifolate therapeutic alternative for cancer chemotherapy;Villela;Pharmacotherapy,2006
3. Phase I and pharmacokinetic study of pemetrexed administered every 3 weeks to advanced cancer patients with normal and impaired renal function [see comment];Mita;J Clin Oncol,2006
4. A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation;Rinaldi;Cancer Chemother Pharmacol,1999
5. Pemetrexed-induced acute renal failure, nephrogenic diabetes insipidus, and renal tubular acidosis in a patient with non-small cell lung cancer;Vootukuru;Med Oncol,2006
Cited by
56 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献